Magnolia Capital Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-304
Closed -$205K 201
2021
Q4
$205K Buy
+304
New +$185K 0.06% 191

Other funds holding AGL

Magnolia Capital Advisors's AGL Position: Q1 2022 in Review

Magnolia Capital Advisors sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 304 shares — an estimated $205K sold.

Magnolia Capital Advisors first reported a position in AGL in Q4 2021 and held it in 1 quarter. The position peaked at $205K in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.

  • Magnolia Capital Advisors reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
  • Magnolia Capital Advisors sold 304 Agilon Health shares in Q1 2022, an estimated $205K.
  • Magnolia Capital Advisors first reported a position in Agilon Health in Q4 2021 and held it in 1 quarter.
  • Magnolia Capital Advisors's Agilon Health position peaked at $205K in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.

Based on Magnolia Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.